Viewing Study NCT04797468


Ignite Creation Date: 2025-12-24 @ 5:36 PM
Ignite Modification Date: 2025-12-28 @ 2:30 PM
Study NCT ID: NCT04797468
Status: WITHDRAWN
Last Update Posted: 2023-01-17
First Post: 2021-03-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 Study of the CD73 Inhibitor(HLX23) Alone in Participants With Solid Tumor
Sponsor: Shanghai Henlius Biotech
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module